W. Feuerer

发表

Pharmacokinetics and systemic effects of tissue‐type plasminogen activator in normal subjects

E. Seifried, D. Rijken, P. Tanswell, 1989, Clinical pharmacology and therapeutics.

First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis

D. Swinkels, L. Matis, K. Budde, 2019, PloS one.

Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.

U. Tebbe, K. Neuhaus, Neuhaus, 1989, Journal of the American College of Cardiology.

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).

M. Gottwik, U. Tebbe, M. Weber, 1988, Journal of the American College of Cardiology.

Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarction (analysis of four German multicenter studies).

U. Tebbe, K. Neuhaus, K. Appel, 1994, The American journal of cardiology.

Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction.

E. Seifried, U. Tebbe, K. Scholz, 1989, The American journal of cardiology.

Pharmacokinetics and Effects on Fibrinolytic and Coagulation Parameters of Two Doses of Recombinant Tissue-Type Plasminogen Activator in Healthy Volunteers

D. Collen, M. Verstraete, P. Tanswell, 1986, Thrombosis and Haemostasis.

[Adjuvant therapy of non-small cell bronchial cancer with mopidamol].

R. Dierkesmann, B. Schneider, C. Geser, 1989, Pneumologie.

Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies.

U. Tebbe, K. Neuhaus, K. Appel, 1993, Journal of the American College of Cardiology.

A Phase I Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of the Hepcidin Antagonist PRS-080#022. Results from a Randomized, Placebo Controlled, Double-Blind Study Following Single Administration to Healthy Subjectsa

D. Swinkels, W. Feuerer, U. Moebius, 2015 .